ViewRay Inc at Morgan Stanley Healthcare Conference Transcript
Let's get going here. My name is David Lewis, Medical Device Analyst here at Morgan Stanley, thanks for sticking with us here as you progress into the afternoon at Day 3 of our 2019 Healthcare Conference. It's my pleasure to have with us here the CEO of ViewRay, Scott Drake. And Scott, I thought before we get into some of the strategic questions, which I think are much more interesting fundamentally long-term, I want to try to deal with a topic at hand, obviously, which is the quarter, right?
Questions & Answers
I think the fundamental question which you've been hearing about a year, the -- there's consistent commercial momentum in this business for 4 straight quarters. And this last quarter, there was a bit of a disconnect in terms of order growth, which obviously had a significant impact on the stock price. Can we just see a breakdown of what you saw on the quarter and what changed?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |